376 related articles for article (PubMed ID: 31497013)
1. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS
Front Immunol; 2019; 10():1921. PubMed ID: 31497013
[TBL] [Abstract][Full Text] [Related]
2. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
[TBL] [Abstract][Full Text] [Related]
3. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
[TBL] [Abstract][Full Text] [Related]
4. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
5. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation.
Nichols JM; Kummari E; Sherman J; Yang EJ; Dhital S; Gilfeather C; Yray G; Morgan T; Kaplan BLF
J Neuroimmune Pharmacol; 2021 Jun; 16(2):346-362. PubMed ID: 32440886
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
[TBL] [Abstract][Full Text] [Related]
7. Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis.
Dopkins N; Miranda K; Wilson K; Holloman BL; Nagarkatti P; Nagarkatti M
J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):15-32. PubMed ID: 34757526
[TBL] [Abstract][Full Text] [Related]
8. miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40.
Mycko MP; Cichalewska M; Cwiklinska H; Selmaj KW
J Neurosci; 2015 Dec; 35(50):16504-15. PubMed ID: 26674874
[TBL] [Abstract][Full Text] [Related]
9. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis.
González-García C; Torres IM; García-Hernández R; Campos-Ruíz L; Esparragoza LR; Coronado MJ; Grande AG; García-Merino A; Sánchez López AJ
Exp Neurol; 2017 Dec; 298(Pt A):57-67. PubMed ID: 28867485
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
Kozela E; Lev N; Kaushansky N; Eilam R; Rimmerman N; Levy R; Ben-Nun A; Juknat A; Vogel Z
Br J Pharmacol; 2011 Aug; 163(7):1507-19. PubMed ID: 21449980
[TBL] [Abstract][Full Text] [Related]
12. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
Giacoppo S; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
Daru; 2015 Oct; 23():48. PubMed ID: 26489494
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
Front Immunol; 2018; 9():1782. PubMed ID: 30123217
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol (3, 5, 4'-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain.
Gandy KAO; Zhang J; Nagarkatti P; Nagarkatti M
J Neuroimmune Pharmacol; 2019 Sep; 14(3):462-477. PubMed ID: 30941623
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Kozela E; Juknat A; Kaushansky N; Rimmerman N; Ben-Nun A; Vogel Z
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1265-76. PubMed ID: 23892791
[TBL] [Abstract][Full Text] [Related]
16. Botanically-Derived Δ
Fitzpatrick JM; Hackett B; Costelloe L; Hind W; Downer EJ
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335126
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol Attenuates
Vitarelli da Silva T; Bernardes D; Oliveira-Lima OC; Fernandes Pinto B; Limborço Filho M; Fraga Faraco CC; Juliano MA; Esteves Arantes RM; A Moreira F; Carvalho-Tavares J
Cannabis Cannabinoid Res; 2024 Apr; 9(2):537-546. PubMed ID: 36745386
[No Abstract] [Full Text] [Related]
18. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
[TBL] [Abstract][Full Text] [Related]
19. Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
Giacoppo S; Soundara Rajan T; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4906-19. PubMed ID: 26744883
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C
Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
